Simple and sensitive assay for quantification of oseltamivir and its active metabolite oseltamivir carboxylate in human plasma using high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry: Improved applicability to pharmacokinetic study
- 4 September 2012
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 72, 245-250
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Oseltamivir in seasonal influenza: cumulative experience in low- and high-risk patientsJournal of Antimicrobial Chemotherapy, 2010
- Studies on the influence of esterase inhibitor to the pharmacokinetic profiles of oseltamivir and oseltamivir carboxylate in rats using an improved LC/MS/MS methodBiomedical Chromatography, 2009
- Sensitive determination of oseltamivir and oseltamivir carboxylate in plasma, urine, cerebrospinal fluid and brain by liquid chromatography–tandem mass spectrometryJournal of Chromatography B, 2008
- Development and validation of a liquid chromatographic–tandem mass spectrometric method for determination of oseltamivir and its metabolite oseltamivir carboxylate in plasma, saliva and urineJournal of Chromatography B, 2007
- Systematic and comprehensive strategy for reducing matrix effects in LC/MS/MS analysesJournal of Chromatography B, 2007
- Sensitivity enhancement in liquid chromatography/atmospheric pressure ionization mass spectrometry using derivatization and mobile phase additivesJournal of Chromatography B, 2005
- Improving LC–MS sensitivity through increases in chromatographic performance: Comparisons of UPLC–ES/MS/MS to HPLC–ES/MS/MSJournal of Chromatography B, 2005
- Influence of the eluent composition on the ionization efficiency for morphine of pneumatically assisted electrospray, atmospheric‐pressure chemical ionization and sonic sprayRapid Communications in Mass Spectrometry, 2002
- Development of a high-performance liquid chromatographic–mass spectrometric assay for the specific and sensitive quantification of Ro 64-0802, an anti-influenza drug, and its pro-drug, oseltamivir, in human and animal plasma and urineJournal of Chromatography B: Biomedical Sciences and Applications, 2000
- Clinical Pharmacokinetics of the Prodrug Oseltamivir and its Active Metabolite Ro 64-0802Clinical Pharmacokinetics, 1999